medroxyprogesterone acetate has been researched along with Atherogenesis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gurney, EP; Nachtigall, LE; Nachtigall, MJ; Naftolin, F | 1 |
| Fischer, JW; Freudenberger, T; Heim, HK; Kojda, G; Marzoll, A; Mayer, P; Oppermann, M; Schrör, K; Weber, AA | 1 |
| Inaba, N; Kurachi, H; Mochizuki, Y; Ohmichi, M; Oishi, A; Takahashi, K | 1 |
| Aldrighi, JM; Lanz, JR; Mansur, AP; Martinez, TL; Ramires, JA | 1 |
| Bots, ML; Evans, GW; Grobbee, DE; Helmond, FA; McBride, KH; Paskett, ED; Riley, W | 1 |
| Christodoulakos, GE; Creatsa, MG; Economou, EV; Kalligerou, I; Lambrinoudaki, IV; Panoulis, CP; Papadias, C; Siasou, Z | 1 |
1 review(s) available for medroxyprogesterone acetate and Atherogenesis
| Article | Year |
|---|---|
The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Topics: Aged; Atherosclerosis; Breast Neoplasms; Calcium; Cognition; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fractures, Bone; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progestins; Randomized Controlled Trials as Topic; Risk Assessment; Stroke; Testosterone; Venous Thromboembolism; Vitamin D; Women's Health | 2014 |
2 trial(s) available for medroxyprogesterone acetate and Atherogenesis
| Article | Year |
|---|---|
The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
Topics: Aged; Atherosclerosis; Double-Blind Method; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Osteoporosis; Treatment Outcome; Tunica Intima; Tunica Media | 2006 |
Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women.
Topics: Adipokines; Adiponectin; Adult; Apoptosis; Atherosclerosis; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Fas Ligand Protein; fas Receptor; Female; Greece; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Resistin; Selective Estrogen Receptor Modulators | 2008 |
3 other study(ies) available for medroxyprogesterone acetate and Atherogenesis
| Article | Year |
|---|---|
Differential effects of medroxyprogesterone acetate on thrombosis and atherosclerosis in mice.
Topics: Animals; Antineoplastic Agents, Hormonal; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Drug Therapy, Combination; Estradiol; Estrogens; Medroxyprogesterone Acetate; Mice; Mice, Knockout; Myocytes, Smooth Muscle; Ovariectomy; Platelet Activation; Thrombin; Thrombosis | 2009 |
Role of glucocorticoid receptor in the inhibitory effect of medroxyprogesterone acetate on the estrogen-induced endothelial nitric oxide synthase phosphorylation in human umbilical vein endothelial cells.
Topics: Atherosclerosis; Cells, Cultured; Contraceptive Agents, Female; Endothelial Cells; Estrogens; Hormone Antagonists; Humans; Medroxyprogesterone Acetate; Mifepristone; Nitric Oxide Synthase Type III; Phosphorylation; Receptors, Glucocorticoid; Risk Factors; RNA, Small Interfering; Umbilical Veins | 2011 |
Effect of sexual steroids on the calcium content of aortic atherosclerotic plaque of oophorectomized rabbits.
Topics: Animals; Aorta; Atherosclerosis; Calcium; Cholesterol; Diet, Atherogenic; Dose-Response Relationship, Drug; Estrogens, Conjugated (USP); Female; Medroxyprogesterone Acetate; Ovariectomy; Rabbits; Random Allocation; Time Factors; Triglycerides | 2005 |